(Q36024376)

English

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status (English)

1 reference

Europe PubMed Central

11 August 2017

0 references

phaeochromocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

Karel Pacak

1 reference

Europe PubMed Central

11 August 2017

Stefan R. Bornstein

4

object named as

Stefan R Bornstein

1 reference

Europe PubMed Central

11 August 2017

Graeme Eisenhofer

1

object named as

Graeme Eisenhofer

1 reference

Europe PubMed Central

11 August 2017

Jacques W M Lenders

2

object named as

Jacques W M Lenders

1 reference

Europe PubMed Central

11 August 2017

author name string

Gabriele Siegert

3

1 reference

Europe PubMed Central

11 August 2017

Peter Friberg

5

1 reference

Europe PubMed Central

11 August 2017

Dragana Milosevic

6

1 reference

Europe PubMed Central

11 August 2017

Massimo Mannelli

7

1 reference

Europe PubMed Central

11 August 2017

W Marston Linehan

8

1 reference

Europe PubMed Central

11 August 2017

Karen Adams

9

1 reference

Europe PubMed Central

11 August 2017

Henri J Timmers

10

1 reference

Europe PubMed Central

11 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 October 2011

1 reference

Europe PubMed Central

11 August 2017

European Journal of Cancer

1 reference

Europe PubMed Central

11 August 2017

48

1 reference

Europe PubMed Central

11 August 2017

11

1 reference

Europe PubMed Central

11 August 2017

1739-1749

1 reference

Europe PubMed Central

11 August 2017

Predictive characteristics of malignant pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Microarray analysis reveals differential expression of benign and malignant pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Gene expression profiling of benign and malignant pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Malignant pheochromocytoma: current status and initiatives for future progress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

The management of benign and malignant pheochromocytoma and abdominal paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Clinical experience over 48 years with pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Pheochromocytomas: can malignant potential be predicted?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

2 October 2017

Pheochromocytoma in Italy: a multicentric retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

27 July 2018

Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

27 July 2018

Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

The value of plasma markers for the clinical behaviour of phaeochromocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

23 September 2018

Changes in Urinary Total Metanephrine Excretion in Recurrent and Malignant Pheochromocytomas and Secreting Paragangliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3372624

5 December 2018

Determination of metanephrines in plasma by liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A re-evaluation of dopamine excretion in phaeochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for malignant pheochromocytoma: analysis of 136 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current Management of Pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22036874

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EJCA.2011.07.016

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36024376&oldid=1867054280"